Publication | Open Access

The protease‐activated receptor 4 Ala120Thr variant alters platelet responsiveness to low‐dose thrombin and protease‐activated receptor 4 desensitization, and is blocked by non‐competitive P2Y12 inhibition

ThrombosisPlatelet Aggregation InhibitorsMolecular PharmacologySignal TransductionBlood PlateletMedicineProtease‐activated Receptor 4HematologyHemostasisPharmacotherapyReceptor 4Non‐competitive P2y12 InhibitionPlatelet AntagonistPharmacologyPlatelet Activation